Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Briefings / Office of Health Economics

Citation Profile [Updated: 2020-06-03 07:38:54]
5 Years H
5
Impact Factor
0
5 Years IF
0
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
1990 0 0.13 0 0 3 3 0 0 3 4 0 0 0.07
1991 0 0.11 0 0 2 5 0 0 4 6 0 0 0.06
1992 0 0.1 0 0 1 6 0 0 5 8 0 0 0.07
1993 0 0.13 0 0 1 7 0 0 3 9 0 0 0.07
1994 0 0.13 0 0 2 9 0 0 2 8 0 0 0.06
1995 0 0.19 0 0 1 10 4 0 3 9 0 0 0.09
1996 0 0.22 0 0 0 10 0 0 3 7 0 0 0.12
1997 0 0.23 0 0 3 13 1 0 1 5 0 0 0.12
1998 0.33 0.24 0.06 0.14 3 16 0 1 1 3 1 7 1 0 0 0.15
1999 0 0.32 0 0 0 16 0 1 6 9 0 0 0.21
2000 0 0.47 0.06 0.14 0 16 0 1 2 3 7 1 0 0 0.2
2001 0 0.4 0 0 0 16 0 2 0 6 0 0 0.22
2002 0 0.41 0 0 0 16 0 2 0 6 0 0 0.23
2003 0 0.42 0 0 1 17 0 2 0 3 0 0 0.24
2004 1 0.47 0.06 1 1 18 0 1 3 1 1 1 1 0 0 0.27
2005 0 0.49 0.11 0 0 18 0 2 5 2 2 0 0 0.29
2006 0 0.48 0.05 0 2 20 0 1 6 1 2 0 0 0.27
2007 0 0.41 0.05 0 1 21 0 1 7 2 4 0 0 0.22
2008 0 0.46 0.04 0.2 5 26 13 1 8 3 5 1 0 0 0.23
2009 0.17 0.43 0.06 0.11 6 32 20 2 10 6 1 9 1 1 50 1 0.17 0.23
2010 0.55 0.37 0.22 0.43 0 32 0 7 17 11 6 14 6 0 0 0.2
2011 0.17 0.47 0.03 0.07 0 32 0 1 18 6 1 14 1 0 0 0.25
2012 0 0.5 0.06 0.17 1 33 0 2 20 0 12 2 0 0 0.26
2013 0 0.52 0.24 0.58 0 33 0 8 28 1 12 7 0 0 0.24
2014 0 0.54 0.29 0.57 1 34 0 10 38 1 7 4 1 10 0 0.28
2015 0 0.54 0.06 0 1 35 0 2 40 1 2 0 0 0.28
2016 0 0.57 0.05 0 2 37 0 2 42 2 3 0 0 0.29
2017 0 0.58 0.11 0 7 44 3 5 47 3 5 3 60 4 0.57 0.28
2018 0 0.6 0.04 0 3 47 0 2 49 9 11 0 0 0.31
2019 0 0.65 0 0 4 51 0 49 10 14 0 0 0.38
IF: Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for series in RePEc in year y
CIF: Cumulative impact factor
IF5: Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12009Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?. (2009). Johannesson, Magnus ; Zethraeus, N ; Kobelt, G ; Jonsson, L. In: Briefings. RePEc:ohe:briefg:000228.

Full description at Econpapers || Download paper

11
22008The Market for Biosimilars: Evolution and Policy Options. (2008). Towse, Adrian ; Mestre-Ferrandiz, J ; Chauhan, D. In: Briefings. RePEc:ohe:briefg:000238.

Full description at Econpapers || Download paper

6
32009Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries. (2009). Garau, Martina ; Mestre-Ferrandiz, J. In: Briefings. RePEc:ohe:briefg:000227.

Full description at Econpapers || Download paper

6
41995Handling Uncertainty in the Results of Economic Evaluation. (1995). Briggs, A. In: Briefings. RePEc:ohe:briefg:000410.

Full description at Econpapers || Download paper

5
52008New Guidelines for Economic Evaluation in Germany and the United Kingdom: Are We Any Closer to Developing International Standards?. (2008). Rutten, F ; Drummond, M F. In: Briefings. RePEc:ohe:briefg:000237.

Full description at Econpapers || Download paper

5
62009American Exceptionalism and American Health Care: Implications for the US Debate on Cost-Effectiveness Analysis. (2009). Neumann, P J. In: Briefings. RePEc:ohe:briefg:000232.

Full description at Econpapers || Download paper

3
72008Challenges and Opportunities for Improving Benefit-Risk Assessment of Pharmaceuticals from an Economic Perspective. (2008). Garrison, L ; Cross, J T. In: Briefings. RePEc:ohe:briefg:000239.

Full description at Econpapers || Download paper

2
82017Additional Elements of Value for Health Technology Assessment Decisions. (2017). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Fischer, A ; Masterson, R ; Mestre-Ferrandiz, J ; Henshall, C ; West, P. In: Briefings. RePEc:ohe:briefg:001851.

Full description at Econpapers || Download paper

2
91997Regulating Prices Paid by the NHS for Medicines Supplied by the UK-Based Pharmaceutical Industry. (1997). Towse, Adrian ; Cave, M. In: Briefings. RePEc:ohe:briefg:000427.

Full description at Econpapers || Download paper

2
102009Deliberative Processes in Decisions about Health Care Technologies. (2009). Culyer, Anthony. In: Briefings. RePEc:ohe:briefg:000231.

Full description at Econpapers || Download paper

1
112003Reducing Harm to Patients in the National Health Service. Will the Governments Compensation Proposals Help?. (2003). Towse, Adrian ; Gray, Alastair ; Salinas, R ; Rickman, N ; Fenn, P. In: Briefings. RePEc:ohe:briefg:000484.

Full description at Econpapers || Download paper

1
122009How Fair? Competition between Independent and NHS Providers to Supply Non-Emergency Hospital Care to NHS Patients in England. (2009). Sussex, J. In: Briefings. RePEc:ohe:briefg:000230.

Full description at Econpapers || Download paper

1
132017Incentives for New Drugs to Tackle Anti-Microbial Resistance. (2017). Towse, Adrian ; Mestre-Ferrandiz, J ; Ferraro, J. In: Briefings. RePEc:ohe:briefg:001842.

Full description at Econpapers || Download paper

1
142017Transferability of HTA. (2017). Towse, Adrian ; Hampson, Grace ; Henshall, C ; Barnsley, P. In: Briefings. RePEc:ohe:briefg:001837.

Full description at Econpapers || Download paper

1
151980Effects of Prescription Charges. (1980). Of, Office . In: Briefings. RePEc:ohe:briefg:000310.

Full description at Econpapers || Download paper

1
162004Developments in Economic Evaluation in Health Care: A Review of HEED. (2004). Pritchard, C. In: Briefings. RePEc:ohe:briefg:000492.

Full description at Econpapers || Download paper

1
172008Health Care Services and the Single European Market. (2008). Mountford, L ; Dawson, D. In: Briefings. RePEc:ohe:briefg:000240.

Full description at Econpapers || Download paper

1
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12009Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries. (2009). Garau, Martina ; Mestre-Ferrandiz, J. In: Briefings. RePEc:ohe:briefg:000227.

Full description at Econpapers || Download paper

2
Citing documents used to compute impact factor:
YearTitle
Recent citations
Recent citations received in 2017
YearCiting document
2017Time for a change in how new antibiotics are reimbursed: Development of an insurance framework for funding new antibiotics based on a policy of risk mitigation. (2017). Towse, Adrian ; Rex, John H ; Hirsch, Mark ; Hoyle, Christopher K ; Mestre-Ferrandiz, Jorge ; Goodall, Jonathan. In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:10:p:1025-1030.

Full description at Econpapers || Download paper

2017Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies. (2017). Towse, Adrian ; Hampson, Grace ; Henshall, C. In: Briefings. RePEc:ohe:briefg:001835.

Full description at Econpapers || Download paper

2017Incentives for New Drugs to Tackle Anti-Microbial Resistance. (2017). Towse, Adrian ; Mestre-Ferrandiz, J ; Ferraro, J. In: Briefings. RePEc:ohe:briefg:001842.

Full description at Econpapers || Download paper

2017Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help?. (2017). Towse, Adrian ; Neri, Margherita. In: Briefings. RePEc:ohe:briefg:001922.

Full description at Econpapers || Download paper